MIRA INFORM REPORT

 

 

Report Date :

11.02.2012

 

IDENTIFICATION DETAILS

 

Name :

ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.

 

 

Registered Office :

Jiangkou Chemical Development Zone, Huangyan Taizhou, Zhejiang Province 318020 Pr

 

 

Country :

China

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

14.02.2003

 

 

Com. Reg. No.:

331003000003258

 

 

Legal Form :

Shares Limited Company

 

 

Line of Business :

Manufacturing pharmaceutical products and pharmaceutical intermediates.

 

 

No. of Employees :

450

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 2,000,000

Status :

Good

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name and address

 

ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD.

JIANGKOU CHEMICAL DEVELOPMENT ZONE, HUANGYAN

TAIZHOU, ZHEJIANG PROVINCE 318020 PR CHINA

TEL: 86 (0) 576-84177669/89189669

FAX: 86 (0) 576-84172669

 

 

EXECUTIVE SUMMARY

 

Date of Registration          : FEBRUARY 14, 2003

REGISTRATION NO.                  : 331003000003258

LEGAL FORM                           : Shares limited company

CHIEF EXECUTIVE                  : TU YONGJUN (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL             : CNY 90,000,000

staff                                      : 450

BUSINESS CATEGORY             : manufacturing

Revenue                                : CNY 441,209,000 (AS OF DEC. 31, 2010)

EQUITIES                                 : CNY 233,673,000 (AS OF DEC. 31, 2010)

WEBSITE                                 : www.tianyupharma.com

E-MAIL                                     : tianyu@tianyupharma.com

PAYMENT                                : AVERAGE

Recommended Credit Limit : UP TO USD 2,000,000

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION                         : FAIRly good

OPERATIONAL TREND              : STEADY

GENERAL REPUTATION                       : AVERAGE

EXCHANGE RATE                     : CNY 6.29 = USD 1

 

 

Adopted abbreviations (as follows)

SC - Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi

 


OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                             General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

Not yet be determined

 

 

LEGAL STATUS & HISTORY

 

SC was established as a limited liabilities company of PRC on February 14, 2003. However, SC changed to present legal form, and was registered as shares limited company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 331003000003258 on June 24, 2011.

 

SC’s Organization Code Certificate No.: 14814421-1

 

SC’s Tax No.: 331003148144211

 

SC’s registered capital: CNY 90,000,000

 

SC’s paid-in capital: CNY 90,000,000

 

Registration Change Record:

Date

Change of Contents

Before the change

After the change

2000-3-15

Legal Representative

Tu Shanzeng

 

Lin Jie

2001-6-29

Registered Capital

CNY 380,000

CNY 2,000,000

2003-1-20

Registered Capital

CNY 2,000,000

CNY 5,000,000

2003-2-14

Company Name

Zhejiang Huangyan Tianyu Chemical Factory

 

Zhejiang Tianyu Chemical Co., Ltd.

2005-5-13

Registered Capital

CNY 5,000,000

CNY 15,000,000

2005-7-21

Legal Representative

Lin Jie

 

Tu Yongjun

Company Name

Zhejiang Tianyu Chemical Co., Ltd.

Zhejiang Tianyu Pharmaceutical Co., Ltd.

2007-8-6

Registration No.

3310032003078

331003000003258

2008-9-12

Registered Capital

CNY 15,000,000

CNY 25,000,000

2009-12-21

Registered Capital

CNY 25,000,000

CNY 50,000,000

2010-11-18

Registered Capital

CNY 50,000,000

CNY 67,880,000

2010-11-23

Registered Capital

CNY 67,880,000

CNY 81,290,000

2010-11-30

Registered Capital

CNY 81,290,000

CNY 86,480,000

2011-6-24

Legal Form

Limited Liabilities Company

Shares Limited Company

Registered Capital

CNY 86,480,000

CNY 90,000,000

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

Name of Shareholder (s)

% of Shareholding

Zhejiang Taizhou Shengting Investment Co., Ltd.

8.91

Shanghai Jinglin Venture Capital Center

4.00

Suzhou Huichuang Investment & Development Co., Ltd.

2.00

Tu Shanzeng

4.34

Wang Juqing

4.34

Tu Yongjun

16.53

Cheng Rongde

0.93

Fang Hongjun

0.93

Li Meijun

0.93

Zhang Yi

0.93

Ma Cheng

1.25

Yang Xuexian

0.65

Wang Yaojie

0.65

Zhou Yunfu

0.17

Zhang Jialiu

0.17

Lin Jie

53.27

 

 

SC’s Chief Executives:-

Position

Name

Legal Representative, Chairman, and General Manager

Tu Yongjun

Director

Fang Hongjun

Wen Zhijun

Wu Chengye

Wang Weisong

Wang Yanguang

Lin Jie

Supervisor

Wang Xiulin

Yang Weiguo

 

 

RECENT DEVELOPMENT

 

Honor

---------

SC becomes one of "top-10 enterprises" of Huangyan region in 2009.

In 2008, SC was approved as "example enterprise in Taizhou city for technical innovation".

SC became a hi-tech enterprise of Zhejiang province in 2008

SC was approved as "key hi-tech enterprise” of China torch program in 2007.

In 2007, SC was approved as "good enterprise" for harmonious labor relationships.

In 2006, SC has passed ISO9001, ISO14001, OHSASA18000 Certificates.

 

 

SHAREHOLDER CHART & BACKGROUND

 

Name                                                                                                               % of Shareholding

 

Zhejiang Taizhou Shengting Investment Co., Ltd.                                                  8.91

 

Shanghai Jinglin Venture Capital Center                                                                           4.00

 

Suzhou Huichuang Investment & Development Co., Ltd.                                                    2.00

 

Tu Shanzeng                                                                                                                 4.34

 

Wang Juqing                                                                                                                 4.34

 

Tu Yongjun                                                                                                                    16.53

 

Cheng Rongde                                                                                                               0.93

 

Fang Hongjun                                                                                                                0.93

 

Li Meijun                                                                                                                       0.93

 

Zhang Yi                                                                                                                       0.93

 

Ma Cheng                                                                                                                     1.25

 

Yang Xuexian                                                                                                                0.65

 

Wang Yaojie                                                                                                                  0.65

 

Zhou Yunfu                                                                                                                    0.17

 

Zhang Jialiu                                                                                                                   0.17

 

Lin Jie                                                                                                                           53.27

 

 

*         Zhejiang Taizhou Shengting Investment Co., Ltd.

=======================================

Registration No.: 331003000063523

Legal Form: Limited Liabilities Company

Chief Executive: Tu Yongjun

Registered Capital: CNY 20,500,000

 

 

*         Shanghai Jinglin Venture Capital Center

=================================

Registration No.: 310115001196944

 

 

MANAGEMENT

 

Tu Yongjun , Legal Representative, Chairman and General Manager

----------------------------------------------------------------------------------------------------

Ø         Gender: M

Ø         Age: 49

Ø         ID# 332603196302180017

Ø         Qualification: University

Ø         Working experience (s):

 

From 2005 to present, working in SC as legal representative, chairman and general manager

 

Director

------------

Fang Hongjun                ID# 330106196210170030

Wen Zhijun                    ID# 110105197712237714

Wu Chengye                 ID# 410103194711182410

Wang Weisong              ID# 310103195911232014

Wang Yanguang            ID# 620102196411085354

Lin Jie                           ID# 332603196901310063

 

 

Supervisor

--------------

Wang Xiulin                   ID# 342901197204033419

Yang Weiguo                 ID# 231021196712050018

 

 

BUSINESS OPERATION

 

SC’s registered business scope includes manufacturing 2,6-difluoroaniline,  raw material drugs, candesartan cilexetil, 4'-methyl-2-cyanobiphenyl, 4-bromomethyl-2’-cyanobiphenyl, sartan, biphenylacetic acid, candesartan cilexetil, irbesartan, telmisartan, eprosartan; manufacturing N, N'-dicyclohexylcarbodiimide (DCC).

 

SC is mainly engaged in manufacturing pharmaceutical products and pharmaceutical intermediates.

 

SC’s products mainly include:

l         Candesartan Cilexetil

l         Valsartan

l         Losartan Potassium

l         Irbesartan

l         Telmisartan

l         Olmesartan Medoxomil

l         Eprosartan Methanesulfonate

l         Montelukast Sodium

 

SC sources its materials 100% from domestic market. SC sells 40% of its products in domestic market, and 60% to overseas market.

 

The buying terms of SC include Check, T/T and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

Staff & Office:

--------------------------

SC is known to have approx. 450 staff at present.

 

SC owns an area as its operating office and factory, but the detailed information is unknown.

 

 

RELATED COMPANY

 

SC is known to have a subsidiary at present:

 

n         Linhai Tianyu Pharmaceutical Co., Ltd.

-----------------------------------------------------

Date of Registration: December 25, 2002

Registration No.: 331082000016154

Legal Form: One-person Limited Liability Company

Chief Executive: Tu Yongjun

Registered Capital: CNY 58,880,000

 

 

 

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

Basic Bank:

 

Bank of China Taizhou Branch Huangyan Sub-branch

 

AC#: 840023559908091001

 

 

FINANCIALS

 

Balance Sheet

Unit: CNY’000

As of Dec. 31, 2009

As of Dec. 31, 2010

Cash

48,696

91,370

Accounts receivable

50,345

64,784

Advances to suppliers

5

5

Subsidies receivable

0

143

Other receivable

1,750

-325

Inventory

39,973

71,936

Prepaid expenses

1,869

1,250

Other current assets

0

4,221

 

------------------

------------------

Current assets

142,638

233,384

Fixed assets

49,569

105,370

Construction in progress

25,159

613

Intangible assets

14,392

14,787

Long-term investment

60,000

86,760

Deferred income tax assets

0

0

Other non-current assets

0

0

 

------------------

------------------

Total assets

291,758

440,914

 

=============

=============

Short-term loans

56,497

53,210

Notes payable

35,000

96,000

Accounts payable

5,809

9,645

Wages payable

0

1,668

Taxes payable

-447

11,361

Advances from clients

0

0

Other payable

3,155

7,877

Other current liabilities

527

480

 

------------------

------------------

Current liabilities

100,541

180,241

Non-current liabilities

52,000

27,000

 

------------------

------------------

Total liabilities

152,541

207,241

Equities

139,217

233,673

 

------------------

------------------

Total liabilities & equities

291,758

440,914

 

=============

=============

 

Income Statement

Unit: CNY’000

As of Dec. 31, 2009

As of Dec. 31, 2010

Revenue

263,837

441,209

     Cost of sales

206,382

340,689

     Taxes and surcharges

1,985

1,923

     Sales expense

4,855

3,624

     Management expense

15,797

35,122

     Finance expense

3,076

8,186

Subsidy income

1,333

529

Non-business income

256

951

     Non-business expense

557

1,297

Profit before tax

32,776

51,897

Less: profit tax

4,917

9,457

Profits

27,859

42,440

 

Important Ratios

=============

 

As of Dec. 31, 2009

As of Dec. 31, 2010

*Current ratio

1.42

1.29

*Quick ratio

1.02

0.90

*Liabilities to assets

0.52

0.47

*Net profit margin (%)

10.56

9.62

*Return on total assets (%)

9.55

9.63

*Inventory / Revenue ×365

56 days

60 days

*Accounts receivable/ Revenue ×365

70 days

54 days

* Revenue/Total assets

0.90

1.00

* Cost of sales / Revenue

0.78

0.77

 

 

 

 

FINANCIAL COMMENTS

 

PROFITABILITY: FAIRLY GOOD

l         The revenue of SC appears fairly good, and it was rising in 2010.

l         SC’s net profit margin is fairly good in both years.

l         SC’s return on total assets is fairly good in both years.

l         SC’s cost of sales is average, comparing with its revenue.

 

LIQUIDITY: AVERAGE

l         The current ratio of SC is maintained in a normal level.

l         SC’s quick ratio is maintained in a normal level.

l         The inventory of SC is maintained in an average level.

l         The accounts receivable of SC is maintained in an average level.

l         SC’s short-term loans are in an average level.

l         SC’s revenue is in an average level, comparing with the size of its total assets.

 

LEVERAGE: FAIRLY GOOD

l         The debt ratio of SC is average in both years.

l         The risk for SC to go bankrupt is low.

 

Overall financial condition of the SC: Fairly good.

 

 

CONCLUSIONS

 

SC is considered medium-sized in its line with fairly good financial conditions. A credit line up to USD 2,000,000 would appear to be within SC’s capacities.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.64

UK Pound

1

Rs.78.35

Euro

1

Rs.65.79

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.